Advances in Lung Transplantation - Royal Perth Hospital

More documents

Recommendations

Info

Post Transplant CMV Prophylaxis Zamora et al Am J of Transplantation 2004;4:1635 90 Post Lung Transplant (donor or recipient CMV positive)recipients received I.V. Ganciclovir (5 mg/kg/bd, 2weeks) plus CMV Immunoglobulin followed by Valganciclovir (450 mg bd) for 180 - 365 days Compared to 140 historical controls who received high dose oral Aciclovir instead of Valganciclovir
Post Transplant CMV Prophylaxis Zamora et al Am J of Transplantation 2004;4:1635 Results: CMV infection: 7.8 % (valgan) v 35%; p
Page 1 and 2: Advances in Lung Transplantation El
Page 3 and 4: Why is Lung Transplantation so diff
Page 5: Protoplasm Surgical Issues - late r
Page 8 and 9: Donor Availability 1. Impact of Don
Page 10 and 11: Maximizing the Utilization of Donor
Page 15 and 16: Treatment Volume status important -
Page 19 and 20: Improvements in Treatment and Preve
Page 21: CMV and Lung Transplantation CMV di
Page 27 and 28: Long Term Problems Thorn in the sid
Page 29 and 30: The real meaning of BOS… BOS is a
Page 31 and 32: The real meaning of BOS… • BOS
Page 33 and 34: CNI Switch from CyA to Tacrolimus:
Page 35 and 36: hange in FEV1 (% pred) after switch
Page 37 and 38: Azithromycin Panbronchiolitis and C
Page 39 and 40: SURGERY Surgery for gastro- esophag
Page 41 and 42: OB: New Therapies are Needed Ration
Page 43 and 44: Azzola A, Havryk A, Chhajed P, Host
Page 45 and 46: Azzola A, Havryk A, Chhajed P, Host
Page 47 and 48: MMF 1.5gm bd 159 patients 40 deaths
Page 49 and 50: Randomized, double-blind study of e
Page 51 and 52: Steering Committee of the Australia
Page 53 and 54: Actuarial survival post lung transp
Page 55: RPH First 8 Transplants How have th

Advances in Lung Transplantation - Royal Perth Hospital

Create successful ePaper yourself

Delete template?

Save as template?